Danaher Corporation (DHR) |
|
Price: $251.4700
$2.07
0.830%
|
Day's High:
| $252.92
| Week Perf:
| -0.64 %
|
Day's Low: |
$ 249.98 |
30 Day Perf: |
1.01 % |
Volume (M): |
3,868 |
52 Wk High: |
$ 269.61 |
Volume (M$): |
$ 972,736 |
52 Wk Avg: |
$236.68 |
Open: |
$250.39 |
52 Wk Low: |
$182.09 |
|
|
Market Capitalization (Millions $) |
186,947 |
Shares
Outstanding (Millions) |
743 |
Employees |
80,000 |
Revenues (TTM) (Millions $) |
23,890 |
Net Income (TTM) (Millions $) |
4,764 |
Cash Flow (TTM) (Millions $) |
-131 |
Capital Exp. (TTM) (Millions $) |
1,383 |
Danaher Corporation
Danaher Corporation derives its sales from the design, manufacture and marketing
of industrial and consumer products, which are typically characterized by strong
brand names, proprietary technology and major market positions, in three business
segments: Professional Instrumentation, Industrial Technologies, and Tools &
Components.
The Company strives to create shareholder value through:
delivering sales growth, excluding the impact of acquired businesses, in excess
of the overall market growth for its products and services;
upper quartile financial performance when compared against peer companies;
and
upper quartile cash flow generation from operations when compared against peer
companies.
To accomplish these goals, the Company uses a set of tools and processes, known
as the DANAHER BUSINESS SYSTEM ('DBS'), which are designed to continuously improve
business performance in critical areas of quality, delivery, cost and innovation.
The Company also acquires businesses that it believes can help it achieve the
objectives described above. The Company will acquire businesses when they strategically
fit with existing operations or when they are of such a nature and size as to
establish a new strategic line of business.
The Company's manufacturing operations employ a wide variety of raw materials.'
While certain raw materials such as steel and certain electrical components
are subject to supply constraints, Danaher believes that it will generally be
able to obtain adequate supplies of major raw material requirements or reasonable
substitutes at reasonable costs.
Competition
Our served markets are generally highly competitive and global in nature.'Because
of the diversity of products the Company manufactures and the variety of markets
it serves, the Company encounters a wide variety of competitors. The Company
faces numerous regional or specialized competitors, many of which are well-established
in their markets.'In addition, some of the Company's competitors are larger
companies or divisions of larger companies that have greater sales, marketing,
research, and financial resources than the Company. Key competitive factors
typically include price, quality, delivery speed, service and support, innovation,
product features and performance, and brand name.
Company Address: 2200 Pennsylvania Avenue, N.W., Suite 800W Washington, 20037 DC
Company Phone Number: 828-0850 Stock Exchange / Ticker: NYSE DHR
|
|
Customers Net Income grew by |
DHR's Customers Net Profit Margin fell to |
11.87 % |
-0.18 %
|
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Personnel Announcements
Published Wed, Mar 13 2024 12:05 PM UTC
Molecular Devices Appoints Mary Duseau as President, Bringing 25 Years of Experience in Life Sciences Molecular Devices, a prominent provider of high-performance life science solutions and an operating company within the life sciences segment of Danaher Corporation, has made a significant leadership change. Today, the company announced the appointment of Mary Duseau as...
|
Danaher Corporation
The stock market is a dynamic and ever-changing entity, with investors constantly searching for opportunities to maximize their returns. In this regard, the recent news of Danaher Corporation's proposed acquisition of Abcam plc has generated a buzz in the global life science research tools industry. This strategic move by Danaher, a renowned leader in the field, highlights their commitment to expanding their foothold in the market and signals potential growth for investors. The acquisition, valued at $24.00 per share in cash, has received approval from the High Court of Justice of England and Wales. This signifies a significant development and presents an exciting opportunity for both Danaher and Abcam plc. The deal is set to be implemented through a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006, ensuring a smooth transition for both companies.
|
Business Update
Published Mon, Dec 4 2023 9:01 PM UTC
In a significant development for the global life science research tools industry, Abcam plc (Nasdaq: ABCM), a renowned leader in the field, has received approval from the High Court of Justice of England and Wales for its proposed acquisition by Danaher Corporation (NYSE: DHR). The deal, valued at $24.00 per share in cash, signifies a strategic move by Danaher to expand...
|
Danaher Corporation
Danaher Corporation, a global science and technology innovator, recently released its financial results for the third quarter of 2023. The company witnessed a decline in both its top and bottom-line, experiencing a drop in earnings per share (EPS) and revenue. These results have sparked speculation and concern about the company's future prospects. This article will analyze the impact of the financial results on Danaher Corporation and explore potential implications moving forward. Earnings and Revenue Drop In the July to September 2023 timeframe, Danaher Corporation reported a significant decline in earnings per share, with a decrease of 28.1%. Revenue also took a hit, dropping by 10.309% year on year. Comparing the third quarter of 2023 to the same period in the previous year, revenue fell to $6.87 billion in contrast to $7.66 billion, while EPS decreased from $2.10 to $1.51.
|
Danaher Corporation
Danaher Corporation, a prominent global science and technology company, has recently witnessed a substantial increase in its stock price over the past year. However, the company's most recent financial results for the second quarter of 2023 have shown a decline in earnings per share (EPS) and revenue. This article aims to interpret these findings and ponder how they may affect the company going forward. 1. Declining EPS and Revenue: In the second quarter of 2023, Danaher Corporation's EPS dropped by -33.78% to $1.49 per share, mainly due to a -7.664% decrease in revenue to $7.16 billion YoY. These numbers indicate a decline in profitability as the company faced challenges amid shifting market dynamics or internal operational factors.
|
Per Share |
Current |
Earnings (TTM) |
6.37 $ |
Revenues (TTM) |
32.14 $
|
Cash Flow (TTM) |
- |
Cash |
-
|
Book Value |
71.95 $
|
Dividend (TTM) |
1.11 $ |
|
Per Share |
|
Earnings (TTM) |
6.37 $
|
Revenues (TTM) |
32.14 $ |
Cash Flow (TTM) |
- |
Cash |
-
|
Book Value |
71.95 $ |
Dividend (TTM) |
1.11 $ |
|
|
|
Environmental |
|
Segment |
|
|
of total Revenue |
Industrial Technologies |
|
Segment |
|
|
of total Revenue |
Test & Measurement |
|
Segment |
|
|
of total Revenue |
Dental |
|
Segment |
|
|
of total Revenue |
Life Sciences & Diagnostics |
|
Segment |
|
|
of total Revenue |
|
|
|